2020
DOI: 10.1016/j.compchemeng.2019.106693
|View full text |Cite
|
Sign up to set email alerts
|

Model uncertainty-based evaluation of process strategies during scale-up of biopharmaceutical processes

Abstract: Model-assisted design of experiments Quality by design a b s t r a c tReliable scale-up of biopharmaceutical production processes is key in Quality by Design. In this study, a model-based workflow is described to evaluate the bioprocess dynamics during process transfer and scale-up computationally. First, a mathematical model describes the bioprocess dynamics of different state variables (e.g., cell density, titer). Second, the model parameter probability distributions are determined at different scales due to… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
57
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

6
2

Authors

Journals

citations
Cited by 28 publications
(59 citation statements)
references
References 52 publications
(53 reference statements)
2
57
0
Order By: Relevance
“…The peak antibody titer was cnormalAb=85mgnormalL1 at the end of the cultivation, as seen in Figure 2H. The product concentrations were comparable to previous studies using the same medium and cell line [43, 48–50].…”
Section: Resultssupporting
confidence: 85%
See 1 more Smart Citation
“…The peak antibody titer was cnormalAb=85mgnormalL1 at the end of the cultivation, as seen in Figure 2H. The product concentrations were comparable to previous studies using the same medium and cell line [43, 48–50].…”
Section: Resultssupporting
confidence: 85%
“…Hence, any effects of pH on cell metabolism were absent. Second, many studies report lactate consumption to occur close to or during the stationary phase, which is usually influenced by cell death mechanisms [42–45]. Therefore, the initial glucose concentration in the medium was reduced to 20mmolnormalL1 (typically 42mmolnormalL1) to maintain steady cell growth and lactate uptake.…”
Section: Resultsmentioning
confidence: 99%
“…The identified population changes can affect process variability with different productivities in large scale, e.g., if cells are pooled from different bioreactors for inoculation [6,22]. Moreover, this study demonstrates the strong impact of preculture treatment on the bulk process performance and the need for an efficient seed train design [54] and scale-up strategy [55]. Regarding the application of the cell labeling concept, the changes in the bulk composition behavior would be not observable if the different populations were not individually marked.…”
Section: Discussionmentioning
confidence: 80%
“…To overcome the previously mentioned limitations of DoE, a new model-assisted Design of Experiments (mDoE) concept was recently introduced for knowledge-driven bioprocess development and optimization [ 1 , 14 , 19 ]. In the mDoE approach, the recommended experiments in statistical DoE designs are simulated using mathematical process models instead of being performed experimentally.…”
Section: Introductionmentioning
confidence: 99%